BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15814676)

  • 1. Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease.
    Aoukaty A; Tan R
    J Immunol; 2005 Apr; 174(8):4551-8. PubMed ID: 15814676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
    Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
    Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
    Aoukaty A; Tan R
    J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective NK cell activation in X-linked lymphoproliferative disease.
    Benoit L; Wang X; Pabst HF; Dutz J; Tan R
    J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways.
    Chuang SS; Kumaresan PR; Mathew PA
    J Immunol; 2001 Dec; 167(11):6210-6. PubMed ID: 11714782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).
    Eissmann P; Beauchamp L; Wooters J; Tilton JC; Long EO; Watzl C
    Blood; 2005 Jun; 105(12):4722-9. PubMed ID: 15713798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
    Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
    Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
    Nakajima H; Colonna M
    Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
    Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG
    Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn.
    Bloch-Queyrat C; Fondanèche MC; Chen R; Yin L; Relouzat F; Veillette A; Fischer A; Latour S
    J Exp Med; 2005 Jul; 202(1):181-92. PubMed ID: 15998796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell function triggered by multiple activating receptors is negatively regulated by glycogen synthase kinase-3β.
    Kwon HJ; Kwon SJ; Lee H; Park HR; Choi GE; Kang SW; Kwon SW; Kim N; Lee SY; Ryu S; Kim SC; Kim HS
    Cell Signal; 2015 Sep; 27(9):1731-41. PubMed ID: 26022178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptor 3BP2 activates CD244-mediated cytotoxicity in PKC- and SAP-dependent mechanisms.
    Saborit-Villarroya I; Martinez-Barriocanal A; Oliver-Vila I; Engel P; Sayos J; Martin M
    Mol Immunol; 2008 Jul; 45(12):3446-53. PubMed ID: 18479751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity.
    Nakajima H; Cella M; Bouchon A; Grierson HL; Lewis J; Duckett CS; Cohen JI; Colonna M
    Eur J Immunol; 2000 Nov; 30(11):3309-18. PubMed ID: 11093147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WhatSAP - 2B4 sends mixed messages in the absence of SAP.
    Watzl C; Claus M
    Eur J Immunol; 2014 May; 44(5):1281-4. PubMed ID: 24659462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adaptor protein 3BP2 binds human CD244 and links this receptor to Vav signaling, ERK activation, and NK cell killing.
    Saborit-Villarroya I; Del Valle JM; Romero X; Esplugues E; Lauzurica P; Engel P; Martín M
    J Immunol; 2005 Oct; 175(7):4226-35. PubMed ID: 16177062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
    Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
    J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C is involved in 2B4 (CD244)-mediated cytotoxicity and AP-1 activation in natural killer cells.
    Chuang SS; Lee JK; Mathew PA
    Immunology; 2003 Jul; 109(3):432-9. PubMed ID: 12807490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.
    Roda-Navarro P; Mittelbrunn M; Ortega M; Howie D; Terhorst C; Sánchez-Madrid F; Fernández-Ruiz E
    J Immunol; 2004 Sep; 173(6):3640-6. PubMed ID: 15356108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.